6G9A
Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2
Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.
| Version Number | Version Date | Version Type/Reason | Version Change | Revised CIF Category | |
|---|---|---|---|---|---|
| 1.0 | 2018-05-30 | Initial release | |||
| 1.1 | 2018-06-13 | Data collection, Database references | citation | ||
| 1.2 | 2018-06-27 | Data collection, Database references | citation | Download |
